Similarly, IGF2BP2/3 manipulate the expression of ephrin type-A receptor 2 (EphA2) and VEGFA to facilitate vasculogenic mimicry in CRC 41. The gene discussed is IGF2BP2; the disease is colorectal carcinoma.